Stay updated on IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial
Sign up to get notified when there's something new on the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page.

Latest updates to the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page
- Check5 days agoChange DetectedThe record history now includes a new version submitted on 2026-10-13, with a study-status update posted the following day. An NIH notice about terminology changes also appears on the page.SummaryDifference0.5%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changes from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check40 days agoChange DetectedA new site revision entry (v3.7.0) has been added to the history, updating the page's underlying platform version.SummaryDifference0.0%

- Check54 days agoChange DetectedNew site revision label (v3.6.6) appears, replacing the previous v3.6.5. This indicates a routine system update to the page without altering study data or visible content.SummaryDifference0.0%

- Check75 days agoChange DetectedThe record history now shows Revision: v3.6.5 as the latest version, replacing the previous v3.6.4, indicating an update to the page's revision history display.SummaryDifference0.0%

- Check89 days agoChange DetectedThe revision history now includes the new site revision v3.6.4 and removes the prior v3.6.3, reflecting a minor maintenance update to the page's footer/versioning.SummaryDifference0.0%

Stay in the know with updates to IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page.